Cholesteatoma of mastoid, bilateral
ICD-10 H71.23 is a billable code used to indicate a diagnosis of cholesteatoma of mastoid, bilateral.
Cholesteatoma of the mastoid is a destructive and expanding growth of skin cells in the middle ear and/or mastoid process. This condition often arises as a complication of chronic otitis media, where repeated infections lead to the accumulation of skin cells and debris in the middle ear. Bilateral cholesteatomas indicate that both sides are affected, which can complicate clinical management and increase the risk of hearing loss and other complications. Patients may present with symptoms such as ear discharge, hearing loss, tinnitus, and sometimes vertigo. Diagnosis is typically confirmed through otoscopic examination, imaging studies like CT scans, and audiometric testing. Management often involves surgical intervention to remove the cholesteatoma and reconstruct the tympanic membrane, with follow-up care to monitor for recurrence. The complexity of this condition lies in its potential to cause significant morbidity, including chronic infections and erosion of surrounding structures, necessitating careful coding and documentation.
Detailed surgical notes, imaging results, and audiometric evaluations.
Patients presenting with chronic ear infections, hearing loss, or post-operative follow-ups.
Ensure clear documentation of the extent of the cholesteatoma and any associated complications.
Comprehensive audiometric evaluations and reports on hearing loss.
Patients undergoing hearing assessments post-cholesteatoma surgery.
Document the impact of cholesteatoma on hearing and any rehabilitative measures taken.
Used for surgical intervention in cases of cholesteatoma.
Surgical notes detailing the procedure and findings.
Otolaryngology specialists must document the extent of the cholesteatoma and any complications.
Common symptoms include ear discharge, hearing loss, tinnitus, and sometimes vertigo. Patients may also experience pain or pressure in the affected ear.
Diagnosis is typically made through otoscopic examination, imaging studies such as CT scans, and audiometric testing to assess hearing loss.
Treatment usually involves surgical intervention to remove the cholesteatoma and reconstruct the tympanic membrane. Follow-up care is essential to monitor for recurrence.
